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EDITORIAL POLICIES
SCOPE OF THE JOURNAL
The Journal of Vascular Surgery is dedicated to the
science and art of vascular surgery and aims to improve
the management of patients with vascular diseases by
publishing relevant papers that report important med-
ical advances, test new hypotheses, and address current
controversies. To achieve this goal, the Journal will
publish original clinical and laboratory studies and
reports and papers that comment on the social, eco-
nomic, ethical, legal, and political factors that relate to
these aims.
PEER REVIEW
Principles of peer review
Objectives. The purpose of peer review is to help
ensure that the published papers are of the highest
quality by (1) advising the editors on the originality of
the work, its importance relative to what has already
been published in the current literature, its relevance
to the objectives of the Journal, its scientific creditabil-
ity, and its acceptability for publication, given the space
that is available; and (2) by suggesting changes and
providing advice and assistance to the authors on
important aspects that may improve their manuscript.
Fairness. The success of peer review requires that
all reviewers exercise careful scientific judgment, be
impartial and equitable, and form a balanced view of
the content of each manuscript. There is no formula
that can guide the reviewers in this task, apart from the
requirement to be objective and fair.
Confidentiality. All documents and information
provided for the purpose of peer review must be kept
entirely confidential. Unauthorized access to papers
must be prevented by storing them in a secure manner.
The documents must not be shared with other col-
leagues. If a reviewer wishes to seek a colleague’s opin-
ion on the scientific merit of a manuscript, the Editors
must be consulted first, and the colleague must adhere
to the same standards of confidentiality.
The manuscript must not be photocopied. When
the review is completed, the documents must be
destroyed or returned to the Journal office.
Any inquiries received by individual reviewers about
a manuscript should be referred to the Editors.
Conflict of interest. The decisions of the Editors
must be fair and objective and they must be seen to be
impartial. Because the final decision on publication
rests with the Editors, their decisions must not be
influenced by the Joint Council of The Society for
Vascular Surgery and the American Association for
Vascular Surgery, the affiliated vascular societies, or
representatives of companies, advertisers, government,
or others who might have conflicts of interest.
Reviewers must decline to review any manuscript
applications with which they may have a conflict of
interest and should avoid reviewing any manuscript if
circumstances exist that could be viewed as affecting
their impartiality. For example, a reviewer should not
review a manuscript submitted by a close personal
friend, individuals from his or her institution, individ-
uals with whom the reviewer has collaborated, or a
scientist with whom the reviewer has had long-stand-
ing scientific or personal differences. When the
reviewer is uncertain as to whether a conflict exists, he
or she should inform the Editor of the circumstances
and the Editor will make the final decision.
The peer review process. Fewer than half of the
manuscripts received by the Journal can be published.
The editors and reviewers, by providing prompt and
authoritative review, aim to optimize the quality of the
published papers.
All submitted manuscripts are reviewed initially by
the Editor-in-Chief, Senior Editor, and/or an
Associate Editor. A submission may be rejected out-
right if at least two of the Editors conclude that it does
not have sufficient merit to warrant publication.
Other manuscripts will be sent to two or three
members of the editorial board or to other expert con-
sultants for external peer review. The identities of these
reviewers are kept confidential. Reviewers are asked to
give the editors a confidential opinion on the impor-
tance, originality, and scientific merit of the manu-
script; rank its importance relative to what has already
been published in the medical literature; and suggest
changes that will improve the paper.
A formal statistical review may be obtained to
ensure that the study population was clearly defined,
that the design of the study was suitable, that appro-
priate statistical methods were used, and that the sub-
sequent conclusions were supported by the data and
their analysis.
If two manuscripts are received on the same subject,
unless both can be accommodated in the Journal, pri-
ority in the review process will be given to the manu-
script that was submitted first as determined by the
postmark. The editor will promptly contact the
authors of the second manuscript to inform them of
the problem and give them the option of submitting
their manuscript to another journal.
Administrative issues related to peer review.
Authors are expected to comply with the published
Information for Authors. The Journal’s requirements
for submission of a manuscript are in accordance with
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the “Uniform Requirements for a Manuscript
Submitted to Biomedical Journals” published in
JAMA 1997;277:927-34. Failure to adhere to these
guidelines may negatively influence the opinions of the
editors and reviewers, and thus the manuscript may be
returned to the author for appropriate revisions in
organization before it is sent out for peer review.
The editors will convey the final decision on the dis-
position of the manuscript to the designated corre-
sponding author along with the reasons for the deci-
sion and the complete or summarized comments from
the reviewers.
If revisions are requested, the editor expects the
authors to revise the manuscript appropriately and
promptly to meet publication deadlines. The authors
must clearly indicate the changes that have been made
and/or explain their difference of opinion with the
reviewers.
At the completion of the peer review process, the
copies of the submitted manuscript will not be
returned to the authors. If the paper is rejected, the
figures will be returned only on request.
The editors will send the reviewers a notification of
their final decision on the disposition of a manuscript
and, when appropriate to the review process, the com-
ments of other reviewers.
All manuscripts and correspondence will be kept
on file for a reasonable period of time before being
destroyed so that questions that may arise can be
answered.
TRANSFER OF COPYRIGHT OWNERSHIP
TO THE JOURNAL
Before a manuscript can be reviewed and pub-
lished, the authors must provide a signed agreement
transferring, assigning, or conveying all copyright
ownership of their manuscript to The Society for
Vascular Surgery and the American Association for
Vascular Surgery. Hence, manuscripts accepted for
publication become the permanent property of the
societies and may not be published elsewhere by the
authors without written permission from the Journal.
The authors must sign the following statement. “The
undersigned author(s) transfer(s), assign(s), or other-
wise convey(s) all copyright ownership of the manu-
script to The Society for Vascular Surgery and the
American Association for Vascular Surgery, in the
event the work or a revised version is published in the
Journal of Vascular Surgery.” If the work is not
accepted by the Journal, this agreement becomes null
and void.
Manuscripts written by employees of the federal
government during the course of their official duties
may not be copyrightable. A separate attached letter
should explain this circumstance.
Subsequent to acceptance for publication, if the
authors withdraw their manuscript, the Journal may
make appropriate charges to cover the production
costs incurred.
Copies of the copyright document will be kept
indefinitely.
An individual may make a single photocopy of a
paper for his or her personal use, but multiple copies
cannot be made without the written permission of the
Journal or from the Copyright Clearance Center.
ORIGINALITY OF MANUSCRIPT
The authors must certify that their article is original,
has not been published previously, and is not under
consideration for publication by another journal. The
authors must sign the following statement. “The
undersigned author(s) warrant(s) that the article is
original in form and substance, a manuscript of similar
content has not been published in print or digital
medium under my (our) authorship, does not infringe
upon any copyright or other proprietary right of any
third party, and is not under consideration by another
journal.”
Previous presentations and abstracts. If the
work has been presented previously at a meeting as an
oral presentation or poster or has been published in
an abstract, a detailed report will be considered for
publication. However, the authors are expected to
submit the details of the previous presentations and
provide the abstracts. In general, manuscripts will not
be considered if the work had been published previ-
ously in full-length conference proceedings or as a
book chapter.
Major update of a previous study. If the submit-
ted manuscript is a major update on the results of a pre-
viously published study, the authors must submit copies
of the previous papers so that the editors can determine
whether the new paper provides significant new infor-
mation or statistical power to warrant publication.
Media releases. The editors recognize that news
organizations have the right to disseminate informa-
tion that may have been obtained from a presentation
at a scientific meeting or through direct discussions
with the author. It is the author’s responsibility to
inform the editors that the work has been reported
previously by a journalist and explain the circum-
stances. In doing so, the authors should supply the edi-
tors with the original media report.
If the results of the study may potentially have a
major impact on patient management, the authors
can request the Editor’s consideration of prompt
review and publication.
Once submitted to the Journal, discussion of the
contents of a manuscript with the media must be
delayed until the publication date of the paper unless
the editors provide prior approval. If the authors pro-
vide additional information to the media during the
peer-review or publication process, the article may be
rejected or withdrawn from publication.
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In some instances, the editors may ask the authors
to prepare a brief press release summarizing the manu-
script. However, as with all papers, further discussion
of the results with the media must be deferred until the
date of publication.
Multiple publication. A joint publication or sec-
ondary publication of a full-length paper in another
journal may be considered if the manuscript contains
important information that deserves to be disseminat-
ed to a significantly different readership than that of
the Journal. The editors of the Journal may grant per-
mission for secondary publication in another journal if
the original report in the Journal is appropriately
acknowledged and the secondary publication follows
the initial publication in the Journal. Abstracts or full-
length summaries of papers presented at meetings may
be published simultaneously in another journal with
permission of the editors of both journals providing an
appropriate acknowledgment is made in each journal.
AUTHORSHIP
It is not appropriate to include an individual as an
author unless he or she has made a significant contri-
bution to the conception or completion of the man-
uscript and is willing to share the responsibility for
the content of the paper. Specifically, each of the
authors should have made a direct and substantial
contribution to the following areas: (1) conceiving
and designing the study and/or analyzing and inter-
preting the data; (2) writing the manuscript or pro-
viding critical revisions that are important for the
intellectual content; and (3) approving the final ver-
sion of the manuscript.
Each of the authors will be expected to sign an author-
ship statement as follows. “The undersigned author(s)
certifies (certify) that I (we) have made a direct and sub-
stantial contribution to the work reported in the manu-
script by participating in the following areas: conceiving
and designing the study and/or analyzing and interpret-
ing the data; writing the manuscript or providing critical
revisions that are important for the intellectual content;
and approving the final version of the manuscript. I (we)
have participated to a sufficient degree to take public
responsibility for the work and believe the manuscript
describes truthful facts.”
If an author has collaborated in a project but does
not meet all the requirements for authorship, he or she
should be recognized in the acknowledgment section
of the manuscript.
The order of the authors’ names is at the discretion
of the coauthors, who may wish to add a footnote
explaining the order of authorship and/or their contri-
butions.
ORIGINAL DATA
The authors must be prepared to provide their orig-
inal data for review by the editors and/or reviewers if
requested. Each author must sign the following state-
ment. “I (we) declare that I (we) shall produce the data
on which the manuscript is based for examination by
the editors or their assignees, should they request it.”
The authors are responsible for keeping their origi-
nal data and experimental notes on file for a reasonable
period of time in case a question should arise about the
manuscript after it has been published.
The authors should consider including a footnote in
the manuscript indicating their willingness to make the
original data available to other investigators through
electronic media to permit alternative analysis and/or
inclusion in meta-analysis.
AUTHORS’ DISCLOSURE OF COMPETITIVE
INTERESTS
The authors’ university, institutional, and/or corpo-
rate affiliations will be acknowledged on the title page
along with sources of funding. In addition, the Journal
expects the authors to disclose any commercial associa-
tions that might represent a conflict of interest in respect
to the manuscript. If a company’s product is mentioned
in a manuscript or other articles, including letters to the
editor and editorials, all authors are expected to declare
whether they have a consulting or employment arrange-
ment or a royalty or stock agreement with the company.
The authors must sign the following statement. “I (we)
do not have any paid or unpaid consulting, employ-
ment, royalty, stock, patent agreement, position or other
financial relationship with any individual, company,
organization with a vested interest in the subject matter
mentioned in the manuscript except as disclosed below
in an attached statement.”
During the review process, this relationship will be
held in confidence.
For articles accepted beginning July 1, 1999, a
competition of interest statement will be published
with each paper (Johnston KW Rutherford RB.
Disclosure of competition of interest JVS 30:200-2,
1999). If a paper is accepted for publication, the
authors will be asked to clarify and update their com-
petitive interest statements. 
Failure to disclose a conflict of interest will be
dealt with according to the following which has been
published in the Journal. (Johnston KW Rutherford
RB. Failure to disclose competitive interest. JVS
31:1306, 2000) “If it is brought to the editors’
attention that an author may have failed to make an
appropriate disclosure, the editors will give the
author the opportunity to explain. If a satisfactory
explanation is not forthcoming, the editors will
bring the issue to the attention of the author’s insti-
tution for clarification. If the oversight can be
explained as an honest mistake, . . . a simple notation
of the error will be published. If there was either self-
deception or a deliberate attempt to conceal a signif-
icant financial competitive interest, the editors will
conclude that this may represent an attempt to
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deceive and may be a violation of public and profes-
sional trust. The editors will publish a notation that
the paper may be unreliable because the author did
not meet the standards of honest disclosure of com-
petitive interests required by the Journal.”
ETHICAL AND ANIMAL EXPERIMENTA-
TION APPROVAL
Human subjects. Manuscripts that involve research
conducted on human subjects must follow the princi-
ples outlined in the Declaration of Helsinki (www.vitre-
oussodiety.org/journal/internet/helsinki.htm) and
include a statement in the Methods section that the
experimental protocol and informed consent were
approved by the Institutional Review Board and that all
subjects gave informed consent. The editors reserve the
right to reject a manuscript if the authors fail to make
these statements in the manuscript or if, at the request
of the Editor, they do not provide appropriate docu-
mentation that their studies had appropriate approval
by their Institutional Review Board and that informed
consent was obtained from each patient.
Animal experiments. Manuscripts that report animal
experiments must include a statement in the Methods
section that the study was approved by the Institutional
Review Board and that the animal care complied with the
Guide for the Care and Use of Laboratory Animals,
Institute of Laboratory Animal Resources, Commission
on Life Sciences, National Research Council.
Washington: National Academy Press, 1996. [http://
stills.nap.edu/readingroom/books/labrats/]
CONSENT TO REPRODUCE PREVIOUSLY
PUBLISHED DATA
It is the authors’ responsibility to obtain written
consent from the copyright owner and the original
author to reproduce direct quotations, tables, or illus-
trations that have appeared in copyrighted material and
to provide complete information regarding their
source. Similarly, permission must be obtained for
tables and figures that have been modified from other
publications.
PATIENT CONSENT FOR REPRODUCING
PHOTOGRAPHS AND CASE HISTORIES
Photographs of identifiable persons must be accom-
panied by signed releases from patients or from both
living parents or guardians of minors.Similarly, consent
must be obtained if a person can be identified from the
case description.
COPYEDITING
A manuscript that is accepted for publication is
subject to copyediting so that it will conform to the
Journal’s standards and style. The revised manuscript
will be returned to the authors for approval. By
approving the changes, the authors accept the
responsibility for the changes made in their manu-
script by the copy editor.
SEQUENCE OF PUBLICATION
In general, manuscripts are published in the order
they are received, providing that the Journal receives
revisions in a timely fashion. Also, subject to the same
limitations, every effort is made to publish the man-
uscripts presented at the annual meeting of The
Society for Vascular Surgery and The American
Association for Vascular Surgery and from the affili-
ated societies as a group. Under unusual circum-
stances, a paper may be assigned priority for early
publication if, in the view of the Editors, it contains
important new information that should be brought
to the attention of the readers immediately.
PUBLISHED DISCUSSIONS
The discussions of papers presented at The Society
for Vascular Surgery and the American Association for
Vascular Surgery and at some of the meetings of the
affiliated societies will be published with the manu-
scripts; however, these discussions are subject to edi-
torial review and only those that enhance the text or
present alternative views will be published.
SCIENTIFIC MISCONDUCT
Misconduct in science was defined by the National
Academy of Sciences, National Academy of
Engineering, and the Institute of Medicine in 1992
as fabrication (ie, making up) of data or results, falsi-
fication (ie, changing) of data or results, or plagiarism
(ie, unauthorized use of the words, data, or ideas of
another person without giving appropriate credit) in
proposing, performing, or reporting research.
Misconduct in science does not include errors in the
scientific method or in experimental design or data
interpretation.In dealing with alleged scientific mis-
conduct, the appropriate steps in the process include
informing the authors of the allegations, requesting
clarification, determining whether the misconduct
did or did not occur, and, to the extent possible,
establishing the intent, ascertaining whether there
were mitigating factors, and making recommenda-
tions for appropriate action. If a charge of scientific
misconduct appears to be justified, it is the editors’
responsibility to refer the matter to the appropriate
individual at the authors’ university or institution
where the work was done.
The university or institution has the responsibility
to investigate alleged scientific misconduct.
If the charge of scientific misconduct is substantiat-
ed, the Journal will print a retraction and may impose
sanctions that could include a restriction on future pub-
lication in the Journal. The decision to issue a retraction
generally must be made by the authors and/or the
appropriate authorities at the university or institution
who have access to the full details of the investigation.
A published retraction will include the title of the orig-
inal article, the same first author as in the original paper,
the reasons why the article is being retracted, the cir-
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cumstances of the case, and a bibliographic reference to
the original paper. The retraction will be listed under a
separate heading in the Table of Contents.
CORRECTION OF ERRORS
As part of scientific process, errors may be discovered
after publication that require clarification, correction, or
retraction of the paper. The editor will handle errors on
an individual basis after discussion with the authors.
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